[ { "publication_date": "2026-06-27", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Ändrade avyttring från BTA till vanlig aktie", "first_report": "", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-13", "volume": 158928.0, "volume_raw": "158928,0", "volume_unit": "Antal", "price": 6.5, "price_raw": "6,50", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 1033032.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-15", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB BTA", "isin": "SE0017770027", "transaction_date": "2026-05-13", "volume": 158928.0, "volume_raw": "158928,0", "volume_unit": "Antal", "price": 6.5, "price_raw": "6,50", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 1033032.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2026-05-15", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Nicklas Westerholm", "person_in_leading_position": "Nicklas Westerholm", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-13", "volume": 286071.0, "volume_raw": "286071,0", "volume_unit": "Antal", "price": 6.5, "price_raw": "6,50", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 1859461.5, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-14", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Henrik Krook", "person_in_leading_position": "Henrik Krook", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-13", "volume": 264880.0, "volume_raw": "264880,0", "volume_unit": "Antal", "price": 6.5, "price_raw": "6,50", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 1721720.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-13", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-13", "volume": 119529.0, "volume_raw": "119529,0", "volume_unit": "Antal", "price": 6.5, "price_raw": "6,50", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 776938.5, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-13", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-13", "volume": 153631.0, "volume_raw": "153631,0", "volume_unit": "Antal", "price": 6.5, "price_raw": "6,50", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 998601.5, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-06-27", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Ändrade avyttring från BTA till vanlig aktie", "first_report": "", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 264880.0, "volume_raw": "264880,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-18", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Nils Hallén", "person_in_leading_position": "Nils Hallén", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 37202.0, "volume_raw": "37202,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-15", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 264880.0, "volume_raw": "264880,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2026-05-15", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Nicklas Westerholm", "person_in_leading_position": "Nicklas Westerholm", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 529761.0, "volume_raw": "529761,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-14", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Henrik Krook", "person_in_leading_position": "Henrik Krook", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 264880.0, "volume_raw": "264880,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-13", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 265620.0, "volume_raw": "265620,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-05-13", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "Ja", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-05-11", "volume": 264880.0, "volume_raw": "264880,0", "volume_unit": "Antal", "price": 0.0, "price_raw": "0,0", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 0.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2026-01-16", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Mats Blom", "person_in_leading_position": "Mats Blom", "position": "Styrelseordförande", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2026-01-14", "volume": 150000.0, "volume_raw": "150000,0", "volume_unit": "Antal", "price": 4.48, "price_raw": "4,48", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 672000.0000000001, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-12-01", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-28", "volume": 25000.0, "volume_raw": "25000,0", "volume_unit": "Antal", "price": 4.79, "price_raw": "4,79", "currency": "SEK", "trading_venue": "LONDON STOCK EXCHANGE - MTF", "transaction_value": 119750.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-12-01", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-28", "volume": 25000.0, "volume_raw": "25000,0", "volume_unit": "Antal", "price": 4.73, "price_raw": "4,73", "currency": "SEK", "trading_venue": "LONDON STOCK EXCHANGE - MTF", "transaction_value": 118250.00000000001, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-12-01", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-28", "volume": 5000.0, "volume_raw": "5000,0", "volume_unit": "Antal", "price": 4.86, "price_raw": "4,86", "currency": "SEK", "trading_venue": "LONDON STOCK EXCHANGE - MTF", "transaction_value": 24300.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-12-01", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-27", "volume": 25000.0, "volume_raw": "25000,0", "volume_unit": "Antal", "price": 4.58, "price_raw": "4,58", "currency": "SEK", "trading_venue": "LONDON STOCK EXCHANGE - MTF", "transaction_value": 114500.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-11-28", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Korrigerat pris per enhet för handeln 2025-11-26", "first_report": "", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-27", "volume": 15000.0, "volume_raw": "15000,0", "volume_unit": "Antal", "price": 4.773, "price_raw": "4,773", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 71595.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-11-28", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-27", "volume": 15000.0, "volume_raw": "15000,0", "volume_unit": "Antal", "price": 4.773, "price_raw": "4,773", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 71595.0, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2025-12-01", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "Ja", "correction_description": "antal aktier har korrigerats", "first_report": "", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-26", "volume": 60000.0, "volume_raw": "60000,0", "volume_unit": "Antal", "price": 3.8711, "price_raw": "3,8711", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 232266.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-12-01", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-26", "volume": 232266.0, "volume_raw": "232266,0", "volume_unit": "Antal", "price": 3.8711, "price_raw": "3,8711", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 899124.9126, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2025-11-28", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "Ja", "correction_description": "Korrigerat pris per enhet för handeln 2025-11-26", "first_report": "", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-26", "volume": 60000.0, "volume_raw": "60000,0", "volume_unit": "Antal", "price": 4.114, "price_raw": "4,114", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 246840.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-11-28", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Christian Sonesson", "person_in_leading_position": "Christian Sonesson", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-26", "volume": 60000.0, "volume_raw": "60000,0", "volume_unit": "Antal", "price": 4.246, "price_raw": "4,246", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 254760.00000000003, "status": "Reviderad", "is_current_report": true }, { "publication_date": "2025-11-28", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Henrik Krook", "person_in_leading_position": "Henrik Krook", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-26", "volume": 25000.0, "volume_raw": "25000,0", "volume_unit": "Antal", "price": 3.94, "price_raw": "3,94", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 98500.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-11-27", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Mats Blom", "person_in_leading_position": "Mats Blom", "position": "Styrelseordförande", "closely_associated": "", "correction": "Ja", "correction_description": "Felstavning", "first_report": "", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-26", "volume": 35000.0, "volume_raw": "35000,0", "volume_unit": "Antal", "price": 4.29, "price_raw": "4,29", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 150150.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-11-27", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Mats Blom", "person_in_leading_position": "Mats Blom", "position": "Styrelseordförande", "closely_associated": "", "correction": "Ja", "correction_description": "Felstavning", "first_report": "", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-11-25", "volume": 180000.0, "volume_raw": "180000,0", "volume_unit": "Antal", "price": 5.24, "price_raw": "5,24", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 943200.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-07-17", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-07-15", "volume": 35000.0, "volume_raw": "35000,0", "volume_unit": "Antal", "price": 5.38, "price_raw": "5,38", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 188300.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-06-11", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Laetitia Szaller", "person_in_leading_position": "Laetitia Szaller", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "EGTX", "isin": "SE0003815604", "transaction_date": "2025-06-05", "volume": 13460.0, "volume_raw": "13460,0", "volume_unit": "Antal", "price": 4.05, "price_raw": "4,05", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 54513.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-06-10", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Nicklas Westerholm", "person_in_leading_position": "Nicklas Westerholm", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-06-05", "volume": 15100.0, "volume_raw": "15100,0", "volume_unit": "Antal", "price": 4.05, "price_raw": "4,05", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 61155.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-06-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-06-04", "volume": 32742.0, "volume_raw": "32742,0", "volume_unit": "Antal", "price": 3.93, "price_raw": "3,93", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 128676.06000000001, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-06-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Henrik Krook", "person_in_leading_position": "Henrik Krook", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-06-02", "volume": 15000.0, "volume_raw": "15000,0", "volume_unit": "Antal", "price": 3.43, "price_raw": "3,43", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 51450.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-06-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Henrik Krook", "person_in_leading_position": "Henrik Krook", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-06-02", "volume": 15000.0, "volume_raw": "15000,0", "volume_unit": "Antal", "price": 3.42, "price_raw": "3,42", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 51300.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-06-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Karl Hård af Segerstad", "person_in_leading_position": "Karl Hård af Segerstad", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-06-02", "volume": 38240.0, "volume_raw": "38240,0", "volume_unit": "Antal", "price": 3.37, "price_raw": "3,37", "currency": "SEK", "trading_venue": "Utanför handelsplats", "transaction_value": 128868.8, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-01-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-01-09", "volume": 39753.0, "volume_raw": "39753,0", "volume_unit": "Antal", "price": 6.75, "price_raw": "6,75", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 268332.75, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-01-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-01-08", "volume": 98567.0, "volume_raw": "98567,0", "volume_unit": "Antal", "price": 6.63, "price_raw": "6,63", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 653499.21, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2025-01-09", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Avyttring", "category": "disposal", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2025-01-07", "volume": 74769.0, "volume_raw": "74769,0", "volume_unit": "Antal", "price": 6.79, "price_raw": "6,79", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 507681.51, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-11-11", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Henrik Krook", "person_in_leading_position": "Henrik Krook", "position": "Annan medlem i bolagets administrations-, lednings- eller kontrollorgan", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2024-11-08", "volume": 65000.0, "volume_raw": "65000,0", "volume_unit": "Antal", "price": 4.31, "price_raw": "4,31", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 280150.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-10-07", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Yilmaz Mahshid", "person_in_leading_position": "Yilmaz Mahshid", "position": "Ekonomichef/finanschef/finansdirektör", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2024-10-07", "volume": 10000.0, "volume_raw": "10000,0", "volume_unit": "Antal", "price": 4.225, "price_raw": "4,225", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 42250.0, "status": "Aktuell", "is_current_report": true }, { "publication_date": "2024-10-07", "issuer": "Egetis Therapeutics AB (publ)", "lei": "549300RZCKGWRUBPMY22", "reporting_person": "Nicklas Westerholm", "person_in_leading_position": "Nicklas Westerholm", "position": "Verkställande direktör (VD)", "closely_associated": "", "correction": "", "correction_description": "", "first_report": "Ja", "share_program": "", "character": "Förvärv", "category": "acquisition", "instrument_type": "Aktie", "instrument_name": "Egetis Therapeutics AB", "isin": "SE0003815604", "transaction_date": "2024-10-07", "volume": 10142.0, "volume_raw": "10142,0", "volume_unit": "Antal", "price": 4.25, "price_raw": "4,25", "currency": "SEK", "trading_venue": "NASDAQ STOCKHOLM AB", "transaction_value": 43103.5, "status": "Aktuell", "is_current_report": true } ]